Notice ID: 2ae75589bc2246fb8af4d52911d3bc28Combined Synopsis/Solicitation
Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant
Archived on September 15, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 8:00 PM UTC−04:00
- Posted
- July 21, 2023
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95023Q00329
- Notice ID
- 2ae75589bc2246fb8af4d52911d3bc28
Description
This is a combined synopsis/solicitation, RFQ number 75N95023Q00329 for a commercial service and is conducted under the authority of the FAR Part 13 Simplified Acquisition Procedures; FAR Subpart 13.5 Simplified Procedures for Certain Commercial Items; and FAR Part 12 Acquisition of Commercial Items and is expected to exceed the simplified acquisition threshold. Please see the attached files for more details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95023Q00329- Market Research
- Combined Synopsis
- Market ResearchMay 19, 2023
Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant
- 2×Combined SynopsisCurrentJul 20, 2023
Therapeutic Oligonucleotide Platform Biologics Chemistry, Manufacturing and Controls (CMC) Subject Matter Expert Consultant
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95023Q00329
Archive Date
Sep 15, 2023
Office Address
Bethesda, MD, 20892